We are reimagining traditional drug discovery through the lens of AI, drawing inspiration from the greatest research lab known to man: Nature. The natural world has always had the harshest of selection criteria: evolution or extinction. In fact many of our most game-changing medicines are derived from nature. Such as Alexander Fleming’s discovery of penicillin, returning to his lab to find mould growing on a discarded Petri dish keeping the bacteria from growing. Today, nearly 100 years on, antibiotics save millions of lives worldwide and have added nearly ten years to our life expectancy.
AMPLY makes this traditional approach to drug discovery relevant again by supercharging it with AI. Any form of life, captured and digitized by next-generation sequencing technology, can be analysed using our platform to discover novel medicines. A billion window sills with a billion petri dishes on them.
We don’t stop there: what we discover digitally is bio-printed, creating a real world molecule which we can test and validate. We have tested our discoveries in leading hospitals and benchmarked them against real diseases that have afflicted real people.
The AMPLY platform connects the digital biological biome to high volume peptide, protein and RNAi extraction technology to unlock a new frontier in drug discovery. The AMPLY discovery cycle for novel compounds is rapid, effective and scaleable.